Your browser doesn't support javascript.
loading
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study.
Felix, Ashley S; Sinnott, Jennifer A; Cohn, David E; Duggan, Máire A; Havrilesky, Laura J; Olawaiye, Alexander B; Mariani, Andrea; Rodriquez, Monica; Brett, Mary Anne; Dinoi, Giorgia; Meade, Caitlin E; Hall, Bobbie; Goldfeld, Ester; Elishaev, Esther; Sherman, Mark E; Suarez, Adrian A.
Affiliation
  • Felix AS; Division of Epidemiology, The Ohio State University College of Public Health, Columbus, OH, United States of America. Electronic address: Ashley.Felix@osumc.edu.
  • Sinnott JA; Department of Statistics, The Ohio State University College of Arts and Sciences, Columbus, OH, United States of America.
  • Cohn DE; Division of Gynecologic Oncology, The Ohio State University College of Medicine, Columbus, OH, United States of America.
  • Duggan MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Havrilesky LJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Duke Cancer Institute, Durham, NC, United States of America.
  • Olawaiye AB; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Hospital of UPMC, Pittsburgh, PA, United States of America.
  • Mariani A; Gynecology and Obstetrics, Mayo Clinic, Rochester, MN, United States of America.
  • Rodriquez M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Brett MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Dinoi G; Gynecology and Obstetrics, Mayo Clinic, Rochester, MN, United States of America.
  • Meade CE; Division of Epidemiology, The Ohio State University College of Public Health, Columbus, OH, United States of America.
  • Hall B; Division of Epidemiology, The Ohio State University College of Public Health, Columbus, OH, United States of America.
  • Goldfeld E; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Hospital of UPMC, Pittsburgh, PA, United States of America.
  • Elishaev E; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Hospital of UPMC, Pittsburgh, PA, United States of America.
  • Sherman ME; Department of Pulmonary Medicine, Mayo Clinic, Jacksonville, FL, United States of America.
  • Suarez AA; Division of Pathology, The Ohio State University College of Medicine, Columbus, OH, United States of America.
Gynecol Oncol ; 178: 130-137, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37862792

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Country of publication: